Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 763 to 812 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
382\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidyl-trna synthetase (ec 6.1.1.21) (histidine--trna ligase) (hisrs). [source:swissprot;acc:p12081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8721.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9188.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
parkinson disease (autosomal recessive, juvenile) 2, parkin isoform 1; parkin. [source:refseq;acc:nm\_004562]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
383\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7115.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7496.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05356\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
384\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgi-142; hepatoma-derived growth factor 2. [source:refseq;acc:nm\_016073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-3 (iroquois homeobox protein 3) (fragment). [source:swissprot;acc:p78415]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8964.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9443.02\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05338\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
385\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-1 (iroquois homeobox protein 1) (fragment). [source:swissprot;acc:p78414]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8964.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9442.82\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
386\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8159.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8594.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05337\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
387\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor (hdgf) (high-mobility group protein 1- like 2) (hmg-1l2). [source:swissprot;acc:p51858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-5 (iroquois homeobox protein 5) (irx-2a). [source:swissprot;acc:p78411]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8966.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9444.64\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05336\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
388\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-2 (iroquois homeobox protein 2) (fragment). [source:swissprot;acc:q9bzi1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8966.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9445.26\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
389\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8159.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8595.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05333\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase p54 (oncogene rck) (dead-box protein 6). [source:swissprot;acc:p26196]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
390\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
toll-like receptor 2 precursor (toll/interleukin 1 receptor-like protein 4). [source:swissprot;acc:o60603]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6983.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7354.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05318\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
391\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tar dna-binding protein-43 (tdp-43). [source:swissprot;acc:q13148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3658.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3144.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16358\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8552.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9004.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05289\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
392\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase mgc2835; atp-dependent rna helicase; apoptosis related protein apr-5; dead box helicase 97 kda. [source:refseq;acc:nm\_024072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3641.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4236.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16339\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7781.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8192.41\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05283\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
393\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cryptochrome 1 (photolyase-like). [source:refseq;acc:nm\_004075]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8673.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9132.05\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4e (eif-4e) (eif4e) (mrna cap-binding protein) (eif-4f 25 kda subunit). [source:swissprot;acc:p06730]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4490.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5222.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16301\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
394\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 3; bai-associated protein 3. [source:refseq;acc:nm\_003933]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7679.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8084.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05279\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
395\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8552.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9003.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05278\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4532.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5269.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16251\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
396\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7680.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05276\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6563.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7627.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16205\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
397\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7679.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8084.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05275\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5367.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6233.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16137\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
398\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7680.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05273\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa-binding protein 2 (hcnp protein) (pp3898). [source:swissprot;acc:q9hcs7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5084.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5904.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16125\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
399\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7680.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05272\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-7 chain precursor. [source:swissprot;acc:p36544]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
400\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type vi (ec 4.6.1.1) (atp pyrophosphate-lyase) (ca(2+)-inhibitable adenylyl cyclase). [source:swissprot;acc:o43306]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6970.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7337.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05272\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type v (ec 4.6.1.1) (atp pyrophosphate-lyase) (adenylyl cyclase) (fragment). [source:swissprot;acc:o95622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gdp-mannose pyrophosphorylase a; mannose-1-phosphate guanylyltransferase (gdp). [source:refseq;acc:nm\_013335]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10800.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10260\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0527\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
402\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat-containing protein 15 precursor (hlib). [source:swissprot;acc:q8tf66]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7934.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8352.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05269\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
403\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8853.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9319.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05269\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
404\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif23 (mitotic kinesin-like protein-1) (kinesin- like protein 5). [source:swissprot;acc:q02241]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10008.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9508.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein lrrc3 precursor. [source:swissprot;acc:q9by71]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
405\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10008.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9508.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
laminin gamma-1 chain precursor (laminin b2 chain). [source:swissprot;acc:p11047]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
406\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase a-like (ec 1.1.1.27). [source:swissprot;acc:q9byz2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05264\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thymic stromal co-transporter. [source:refseq;acc:nm\_033051]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/